Signify Health Investor Conference Presentation Deck
-> Attractive financial model, growth, and profitability
$502
signifyhealth.
2019
Revenue (¹) ($ in millions)
CAGR: 23% (3)
$611
2020
$745-765E
2021
Guidance (4)
Adj. EBITDA (1,2) ($ in millions)
$93
2019
CAGR: 31%(3)
$125
2020
1) Remedy acquisition completed on 1/15/2019
2) We define Adjusted EBITDA as net income (loss) before interest expense, income tax expense, depreciation and amortization and certain items of income and expense, including asset impairment, other (income) expense, net
transactions-related expenses, equity-based compensation, remeasurement of contingent consideration, loss on extinguishment of debt, management fees and non-recurring expenses. See slide titled "Reconciliation from GAAP net loss to
Adjusted EBITDA" for a reconciliation of Adjusted EBITDA to net loss and the calculation of Adjusted EBITDA Margin
3) Reflects mid-point of 2021 guidance range
4) Guidance as of August 11, 2021
$155-165E
2021
Guidance (4)
16View entire presentation